View on Pubmed.gov 25973309 View on doi.org
Reactive oxygen species regulate the differentiation of acute promyelocytic leukemia cells through HMGB1-mediated autophagy.
- Department of Pediatrics, Xiangya Hospital, Central South University Changsha, Hunan 410008, People's Republic of China.
- Department of Nuclear Medicine, Affiliated Tumor Hospital, Xiang-Ya Medical School, Central South University Changsha, Hunan 410008, People's Republic of China.
- Department of Surgery, Hillman Cancer Center, University of Pittsburgh G.21, 5117 Centre Avenue, Pittsburgh, PA 15213, USA.
Abstract
Acute promyelocytic leukemia (APL) results from a blockade of granulocyte differentiation during the promyelocytic stage. As a fusion protein of promyelocytic leukemia (PML) and retinoic acid receptor-α (RARα), PML-RARα oncoprotein is degraded through the differentiation of all-trans retinoic acid (ATRA)-induced cells. Here reactive oxygen species (ROS) and high-mobility group box 1 (HMGB1) were proven essential for the differentiation of APL cells. A down-regulation of ROS by ROS quencher (NAC) blocked the differentiation of APL cell line NB4 while an over-expression of ROS by superoxide dismutase-1 (SOD1) RNA interference (RNAi) increased cell differentiation. HMGB1 was vital for the differentiation of ROS-mediated NB4 cells and its up-regulation promoted ATRA-induced autophagy and the degradation of PML-RARα. Furthermore, ATRA treatment elevated the levels of ROS, enhanced autophagic flux and thereby promoted cytosolic translocation of HMGB1. HMGB1 regulated the interactions between ubiquitin-binding adaptor protein p62/SQSTM and PML-RARα so as to affect the degradation of PML-RARα during ATRA-induced autophagy. Also a depletion of p62/SQSTM1 expression inhibited HMGB1-mediated PML-RARα degradation and cell differentiation. The overall results suggested that HMGB1 is an essential regulator of ROS-induced cell differentiation. And it may become a potential drug target for therapeutic intervention of APL.
References
Int J Mol Med. 2012 Jan;29(1):65-72
Autophagy. 2011 Apr;7(4):401-11
Autophagy. 2011 Aug;7(8):904-6
Proc Natl Acad Sci U S A. 1981 Oct;78(10):5988-92
Cited by 27 citations (total)
Journal Article
5-Aminoimidazole-4-carboxamide ribonucleoside-induced autophagy flux during differentiation of monocytic leukemia cells.
Electronic publication date October 5, 2017
Vilma Dembitz [...] Dora Visnjic et al.
Pharmacological modulators of AMP-dependent kinase (AMPK) have been suggested in treatment of cancer. The biguanide metformin and 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR)...
Journal Article Research Support, Non-U.S. Gov't
Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions.
Electronic publication date May 14, 2022
Kristina Seiler [...] Bruce E Torbett et al.
The family of hexokinases (HKs) catalyzes the first step of glycolysis, the ATP-dependent phosphorylation of glucose to glucose-6-phosphate. While HK1...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •